Cyclacel Limited

Cyclacel is a biopharmaceutical company that designs and develops small molecule drugs that act on cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. Our discovery integrates cell cycle biology expertise with a library of gene-based targets, RNAi functional genomics, chemogenomics and clinical biomarker technologies to rapidly deliver new drugs.

Further Information: http://www.cyclacel.com/